Atlas Trials

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

Clinical trial NCT02947334 · WITHDRAWN

Trial details

NCT number
NCT02947334
Sponsor
Pfizer
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Hyperlipidemia or Mixed Dyslipidemia
Start date
2016-10-31
Primary completion
2019-05-03
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.